WCAG Audit for Pharma Patient Websites: What We Found on a Rare Disease Site
A WCAG 2.2 audit of a pharma patient website reveals five critical barriers on a rare disease site — contrast, focus, alt text, and more. H…
A WCAG 2.2 audit of a pharma patient website reveals five critical barriers on a rare disease site — contrast, focus, alt text, and more. H…
A pharma website accessibility audit reveals the same structural failures every time—broken palettes, untagged PDFs, skip-level headings. H…
A WCAG audit of a pharma website checks EN 301 549 compliance under the European Accessibility Act — colour contrast, PDFs, cookie banners,…
A WCAG audit pharma disease awareness website must pass under the European Accessibility Act from June 2025—here's what a rigorous audit ac…
Pharma design system AI compliance uses semantic tokens in Figma to enforce brand rules across markets automatically—here's what works in 2…
A pharma website WCAG accessibility audit of Amgen Belgium's osteoporosenews.be uncovered 11 critical barriers blocking screen-reader users…
A design system accessibility audit fixes WCAG issues at the source in Figma before they ship—here's what works for EAA-ready pharma teams.
A rare disease patient website works when it shortens the path from symptom to specialist. Plain language, multilingual content, and co-cre…
The pharma MLR review process slows down before submission, not during it. Fix co-creation, modular content, and source marking — here's wh…
Rare disease patient communication fails on architecture, not volume. Symptom-led content, plain language, and clear specialist pathways ar…
Pharma patient website accessibility failures hurt the patients who need these sites most. A WCAG audit of Amgen's osteoporosis site scored…
Self-administration injectable therapy patient training is now a regulatory and commercial must. Learn how closing the communication gap dr…
One short email when we publish. No spam, no sales pitch. Unsubscribe whenever.